Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of the Quality of Life of Patients With Post-thrombotic Syndrome Who Receive Compression Therapy and Sulodexide - SQUARES Study

NCT02512601 is registered in ClinicalTrials.gov with Bama GeVe, S.L.U. as lead sponsor.

NCT NCT02512601
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02512601 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of the Quality of Life of Patients With Post-thrombotic Syndrome Who Receive Compression Therapy and Sulodexide - SQUARES Study
Lead sponsor
Bama GeVe, S.L.U.
Phase
Phase 4
Overall status
Terminated
Start date
September 30, 2015
Completion date
February 28, 2017
Enrollment
13 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

post-thrombotic syndrome